{
  "retracted": false,
  "timestamp": 1586131200000,
  "updates": [
    {
      "timestamp": 1589046152322,
      "identifier": {
        "doi": "10.1007/s40259-020-00423-0"
      },
      "type": "correction"
    }
  ],
  "identifier": {
    "doi": "10.1007/s40259-020-00409-y"
  },
  "journal": "BioDrugs",
  "publisher": "Springer Science and Business Media LLC",
  "title": "Correction to: Effectiveness of Switching from Reference Product Infliximab to Infliximab-Dyyb in Patients with Inflammatory Bowel Disease in an Integrated Healthcare System in the United States: A Retrospective, Propensity Score-Matched, Non-Inferiority Cohort Study"
}
